Active ingredientPardoprunoxCat. No. P-P021-001CAS 269718-84-5Family · Pharmaceutical analytical standards
Pardoprunox
A partial agonist of dopamine D2 and D3 receptors and a full agonist of serotonin 5-HT1A receptors, studied in the 2000s up to phase III for Parkinson's disease; development was later discontinued. This family brings together the active ingredient, nitrosamines and other impurities.
Did you know?It was also evaluated for depression and anxiety: it was hoped that, as only a partial dopamine agonist, it would avoid side effects common to dopaminergic drugs, such as dyskinesia and psychosis.
Go to the active ingredient →Active ingredientPardoprunoxCat. No. P-P021-001CAS 269718-84-5
Active ingredientPardoprunox HClCat. No. P-P021-002CAS 269718-83-4
NitrosamineN1-Nitroso-N-Desmethyl PardoprunoxCat. No. P-P021-003
Impurity7-Amino-2(3H)-benzoxazoloneCat. No. P-P021-004CAS 81282-60-2
ImpurityN-Desmethyl PardoprunoxCat. No. P-P021-005CAS 105685-26-5No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.